Is somatic RET mutation a prognostic factor for sporadic medullary thyroid carcinoma?

Affiliations

Comment

Jan Zedenius. Nat Clin Pract Endocrinol Metab. 2008 Aug.

. 2008 Aug;4(8):432-3.

doi: 10.1038/ncpendmet0866. Epub 2008 Jun 10.

¹ Department of Molecular Medicine and Surgery, Karolinska University Hospital, Stockholm, Sweden. jan.zedenius@ki.se

No abstract available

Comment on

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
Elisei R, Cosci B, Romei C, Bottici V, Renzini G, Molinaro E, Agate L, Vivaldi A, Faviana P, Basolo F, Miccoli P, Berti P, Pacini F, Pinchera A. Elisei R, et al. J Clin Endocrinol Metab. 2008 Mar;93(3):682-7. doi: 10.1210/jc.2007-1714. Epub 2007 Dec 11. J Clin Endocrinol Metab. 2008. PMID: 18073307